A COHORT STUDY TO EVALUATE IMMUNOGENICITY FOR CHINESE CHILDREN AT THE TIME OF CLINICAL PNEUMONIA DIAGNOSIS

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 15, 2019

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions
Immunogenicity, Vaccine
Interventions
BIOLOGICAL

PCV13 PAC study

To test the serotype-specific IgG geometric mean concentration (GMC) and MOPA geometric mean titers (GMT) for each of the pneumococcal serotypes measured at the time of diagnosis of clinical pneumonia.

Trial Locations (1)

215003

Children's Hospital of Soochow University, Suzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY